Position in PFE
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$456,087,336
-$29,435,323 QoQ
Shares Held
18,940,504
+9.5% QoQ
Ownership
0.332%
of shares outstanding
% of Portfolio
0.83%
of 13F equity value
Holder Rank
#31
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 64%
Shared 0%
None 36%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LSV ASSET MANAGEMENT holds $2,451,058,699 across 9 Drug Manufacturers - General names. PFE ranks #3 (18.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
5,299,408 | $680,973,928 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
9,852,232 | $567,685,607 | |
| 3 | PFE |
Pfizer Inc
This page
|
18,940,504 | $456,087,336 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
2,635,721 | $332,996,991 | |
| 5 | AMGN |
Amgen Inc
|
603,549 | $218,557,163 | |
| 6 | BIIB |
Biogen Inc.
|
444,049 | $95,941,226 | |
| 7 | OGN |
Organon & Co.
|
3,737,036 | $50,599,467 | |
| 8 | JNJ |
Johnson & Johnson
|
184,693 | $46,906,481 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $456,087,336 | 18,940,504 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $485,522,659 | 17,290,693 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $435,817,578 | 17,502,714 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $431,206,626 | 16,923,337 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $391,475,006 | 16,149,959 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $383,979,908 | 15,153,114 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $364,853,612 | 13,752,492 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $374,636,316 | 12,945,277 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $328,813,965 | 11,751,750 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $342,857,910 | 12,355,240 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $383,360,154 | 13,315,740 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $468,873,473 | 14,135,468 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $535,299,410 | 14,593,768 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $705,338,894 | 17,287,718 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $915,854,434 | 17,873,818 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $837,222,665 | 19,132,145 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,013,762,886 | 19,335,550 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,082,622,057 | 20,912,151 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,271,030,464 | 21,524,648 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $947,705,909 | 22,034,548 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $855,197,696 | 21,838,552 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $815,681,024 | 22,513,967 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $826,048,351 | 22,440,868 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $876,790,320 | 23,890,768 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $830,537,302 | 25,398,668 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $874,511,499 | 26,792,668 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||